Evidence map›Paper›PMID 41007660›Full record

ArticleBiomedicines2025

Investigating the Pharmacological Impact of Atosiban, an Oxytocin Receptor Antagonist, on Bladder and Prostate Contractions Within OBESE and Non-Obese Rats.

Masroor Badshah, Jibriil Ibrahim, Nguok Su, Penny Whiley, Sarah M Turpin-Nolan, Khaled A Elnahriry, Ralf Middendorff, Michael Whittaker, Betty Exintaris

Abstract read
PubMed Full text at PMC Publisher
In one paragraph

Article in Biomedicines, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 1 paper.

0numbers the graph read from it
0cells of the map it votes in
1citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

1 citing paper in PubMed.

  1. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

9 authors.

Masroor BadshahHudson Institute of Medical Research, Monash University, Clayton, VIC 3168, Australia.
Jibriil IbrahimMonash Institute of Pharmaceutical Sciences, Parkville, VIC 3052, Australia.
Nguok SuHull York Medical School, University of Hull, Hull HU6 7RX, UK.
Penny WhileyHudson Institute of Medical Research, Monash University, Clayton, VIC 3168, Australia.
Sarah M Turpin-NolanMonash Institute of Pharmaceutical Sciences, Parkville, VIC 3052, Australia.
Khaled A ElnahriryDepartment of Pharmaceutical Sciences, College of Pharmacy, Alfaisal University, Riyadh 11533, Saudi Arabia.
Ralf MiddendorffInstitute of Anatomy and Cell Biology, Justus-Liebig-University, 35390 Giessen, Germany.ORCID 0000-0002-5390-2564
Michael WhittakerMonash Institute of Pharmaceutical Sciences, Parkville, VIC 3052, Australia.ORCID 0000-0001-5706-3932
Betty ExintarisMonash Institute of Pharmaceutical Sciences, Parkville, VIC 3052, Australia.ORCID 0000-0002-3260-2175

Funding

Deutsche Forschungsgemeinschaft, Germany, and Monash University, Australia, through the International Research Training Group (IRTG) collaboration between Justus-Liebig University Giessen and Monash University Clayton. GRK 1871
6 · The paper itself

Abstract

PubMed holds no abstract for this paper.

Indexed as

benign prostatic hyperplasialower urinary tract symptomsoveractive bladderoxytocin receptor antagonist

Identifiers

PMID41007660
PMCPMC12467195

What Socratic holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.